Health Care Sector
Itolizumab, a monoclonal antibody developed by the Center of Molecular Immunology (CIM) in collaboration with Biocon, India’s largest pharmaceutical company, received authorization to begin...
Hi, what are you looking for?
All posts tagged "CIM"
Health Care Sector
After 25 long years of studies and innumerable clinical trials which took place in Canada, the United Kingdom, Malaysia, China and at the Roswell...
Health Care Sector
Established in 1991, the Center of Molecular Immunology (Centro de Inmunologia Molecular) (CIM) situated in Playa, west of Havana, is a biotechnological institution dedicated...